Joseph A. Sowell III - 16 Feb 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role: SVP; Chief Development Officer
Signature: /s/ Natalie Harrison Cline, Attorney-in-Fact
Issuer symbol: HCA
Transactions as of: 16 Feb 2024
Transactions value $: -$618,643
Form type: 4
Filing time: 21 Feb 2024, 19:34:29 UTC
Previous filing: 02 Feb 2024
Next filing: 17 May 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	HCA	Common Stock	Award	$0	+6.28K		$0.00	6.28K	16 Feb 2024	Direct	F1
transaction	HCA	Common Stock	Tax liability	-$619K	-2.01K	-31.93%	$308.55	4.28K	16 Feb 2024	Direct
holding	HCA	Common Stock						29.8K	16 Feb 2024	By 2023 Spouse Trust
holding	HCA	Common Stock						5.16K	16 Feb 2024	By 2023 Trust
holding	HCA	Common Stock						8K	16 Feb 2024	By Trust (Reporting Person, Trustee)
holding	HCA	Common Stock						0	16 Feb 2024	By Spouse	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	On February 3, 2021, the reporting person was granted 3,140 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.
F2	On November 14, 2023, a Form 4 was filed for the reporting person, and due to an administrative error, the cumulative amount in column 5 was incorrectly reported as 29,771. The amount of securities beneficially owned is corrected herein.

Content

On February 3, 2021, the reporting person was granted 3,140 performance share units. The performance share units were eligible to vest based on achievement of a cumulative earnings per share goal for fiscal years 2021-2023. The number of performance share units that were eligible to vest varied from zero (for actual performance less than 90% of target) to two times the units granted (for actual performance of 110% or more of target). Based upon the Company's achievement with respect to cumulative 2021-2023 earnings per share, the number of performance share units that vested equaled 200% of the units granted.

On November 14, 2023, a Form 4 was filed for the reporting person, and due to an administrative error, the cumulative amount in column 5 was incorrectly reported as 29,771. The amount of securities beneficially owned is corrected herein.